Additional File 2: of A Chinese Family Affected by Lynch Syndrome Caused by MLH1 Mutation

Shuqin Jia,Meng Zhang,Yu Sun,Hai Yan,Fangping Zhao,Ziyu Li,Jiafu Ji

DOI: https://doi.org/10.6084/m9.figshare.6651506

2018-01-01

Abstract:Table S2. All six family members gene test result. All six family members gene test results displayed in order of gene. (XLSX 770Â kb)

What problem does this paper attempt to address?

A Chinese family affected by lynch syndrome caused by MLH1 mutation

Shuqin Jia,Meng Zhang,Yu Sun,Hai Yan,Fangping Zhao,Ziyu Li,Jiafu Ji

DOI: https://doi.org/10.1186/s12881-018-0605-x

2018-01-01

BMC Medical Genetics

Abstract:Background Lynch syndrome (LS) is caused by mutations in DNA mismatch repair (MMR) genes, which accounts for 3–5% of colorectal cancer. The risks of several types of cancer are greatly increased among individuals with LS. In this study, 4 members of a Chinese family with a MLH1 pathogenic variant, resulting in colonic carcinoma, was reported. Case presentation A 52-year-old colon cancer female was brought to us with a family history of colon cancer. Genetic counseling traced 4 members in her family with colon cancer (mother and 3 siblings including the proband) as well as other cancer types. Next generation sequencing (NGS) with a multiple gene panel including MMR genes showed a germline mutation in MLH1 (c.1852_1854delAAG, p.K618del) in all 3 affected family members and confirmed the diagnosis of Lynch syndrome. In addition, this mutation was also identified in a asymptomatic offspring, who was then recommended to a prophylactic measure against cancer. A personalized health care plan was implemented for monitoring the condition and progression of the affected individuals. Conclusion Based on public database searching followed by pedigree verification, p.K618del variant in MLH1 is a pathogenic mutation, which supported the diagnosis of LS. This case highlights the importance of diagnosis and management in patients with hereditary cancer syndromes, particularly for asymptomatic family members.
Novel Germline Mutations in MLH1 and PMS2 in Familial Lynch Syndrome

Yuhan Cai,Xiaohan Chang,Congrong Liu,Qianqian Lin,Hua Li

DOI: https://doi.org/10.1016/j.gocm.2022.04.005

2022-01-01

Gynecology and Obstetrics Clinical Medicine

Abstract:•A Chinese family with Lynch syndrome was introduced.•Two novel germline mutations at MLH1 and PMS2 were found in this family.•3D structure maps of the two mutant proteins were made and were compared with the wild type 3D structure maps.
A novel heterozygous large deletion of MSH6 gene in a Chinese family with Lynch syndrome

Yuanyuan Liu,Mingwei Wang,Qiongrong Chen,Qiaosong Zheng,Guangyu Li,Qian Cheng,Sanhe Liu,Shengwei Ye

DOI: https://doi.org/10.1016/j.gene.2019.04.011

IF: 3.913

2019-07-01

Gene

Abstract:Lynch syndrome (LS) is a common cancer syndrome that is inherited in an autosomal dominant manner. Its pathogenesis is thought to be closely related to germline mutations of mismatch repair (MMR) genes such as the MLH1, MSH2, PMS2 and MSH6 genes. This study identifies a Chinese family with LS clinically diagnosed according to the Amsterdam II criteria. In these patients, immuno-histochemical staining showed negative MSH6 expressions but positive MLH1, MSH2, and PMS2 expressions. In order to further explore the molecular biology of this LS family, we used targeted next-generation sequencing (NGS) and Multiplex ligation dependent probe amplification (MLPA) to identify the mutation and verify the authenticity of the mutation in 15 family members. For NGS, two panels have been used, one is of MLH1, MSH2, PMS2 and MSH6 genes, the other one is of 139 cancer genetic susceptibility genes. And for the large deletions/duplications can also be identified by NGS panel, an adjusted data analysis strategy of NGS has been used. As a result, we identified a novel heterozygous large deletion in MSH6 gene that was found to be co-segregated among affected family members. This deletion results in the loss of a 3246 bp-sized fragment in MSH6 gene exons 5-9 which represents the coding regions of the MSH6 ATPase domain. This novel mutation has yet to be documented in the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) database. This mutation resulted in MSH6 protein losing gene mismatch repair function, and further caused the microsatellite instable. We speculate that this mutation may significantly impact MMR function through impaired ATP domain function. Theoretically, this proband would likely benefit from PD-1 immune check-point blockade therapy, but conversely, we observed that tumors appeared to rapidly progress after 4 sessions of anti-PD-1 treatment. Further studies to validate the effectiveness of anti-PD-1 treatments in carriers of this mutation are necessary.
Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Pengyuan Liu,Haris G. Vikis,Yan Lu,Yian Wang,Ann G. Schwartz,Susan M. Pinney,Ping Yang,Mariza de Andrade,Adi Gazdar,Colette Gaba,Diptasri Mandal,Juwon Lee,Elena Kupert,Daniela Seminara,John Minna,Joan E. Bailey-Wilson,Christopher I. Amos,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/1055-9965.22435836.v1

2023-01-01

Abstract:Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer
A Novel MLH1 Initiation Codon Mutation (c.3g>t) in a Large Chinese Lynch Syndrome Family with Different Onset Age and Mrna Expression Level

Yanni Zhang,Huishuang Chen,Zhiyu Peng,Santasree Banerjee,Wei Li,Zhaolong Zhao,Jianbin Sun,Jian Lv,Hui Huang,Ru Bai,Keke Lin,Zhongxin Li

DOI: https://doi.org/10.1155/2018/1460835

2018-01-01

BioMed Research International

Abstract:Lynch syndrome is a genetically and clinically heterogeneous disorder; it is caused by a germline mutation in DNA mismatch repair (MMR) genes. Individuals with a heterozygous mutation in MLH1 have an increased risk for developing colorectal cancer. Here we described a 5-generation Chinese Lynch syndrome family with different severity and onset age. A novel heterozygous germline mutation (c.3G>T, p.Met1Ile) in MLH1 gene was discovered by next generation sequencing. Our study also revealed by qPCR that the MLH1 mRNA expression in peripheral blood of patients in this family was remarkably lower than that of the unaffected carriers and non-carriers. The research results indicated that the mRNA expression level may provide predictive suggestions of treatment and management for carriers with the initiation codon mutation of MLH1 in this family. Further studies are undertaken in this family as well as other families with Lynch syndrome to interrogate the exact reasons affecting the MLH1 mRNA expression level and whether mRNA expression in peripheral blood could be a significant factor for early diagnosis and surveillance of Lynch syndrome.
The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Ming Zhu,Xiao-rong Liu,Yan-qin Huang,Ying Yuan,Jin-tian Li,Xiao-mei Zhang,Yuan-ying Zhang,Ya-ping Wang

DOI: https://doi.org/10.3760/j.issn:1003-9406.2005.06.002

2005-01-01

Abstract:OBJECTIVE:To investigate the frequency of large fragment aberrations of MSH2 and MLH1 genes from Chinese colorectal cancer (CRC) patients with family history.METHODS:Sixteen exons of MSH2, nineteen exons of MLH1 and seven DNA sequences from the other genes of the samples were screened and checked by multiplex ligation dependent probe amplification (MLPA). First, the methodology was confirmed by testing the positive and negative control samples. Then, 32 CRC or hereditary nonpolyposis colorectal cancer (HNPCC) patients with family history and 20 cases of sporadic CRC were applied to investigate for the large fragment aberrations of MSH2 and MLH1 genes.RESULTS:The genomic DNA fragment deletions of all positive controls were identified and verified by MLPA. Three cases of 32 familial (hereditary) CRC/HNPCC were detected and identified to be the germline heterozygous deletions of MSH2 gene, of which exons 1-7 were deleted from patient No.3, exon 11 from No.25 and exons 2-6 from No.11. However, no genomic DNA fragment aberration of either MSH2 or MLH1 gene was uncovered from 20 sporadic CRC.CONCLUSION:Large DNA fragment aberrations of MSH2 gene was a frequent cause of Chinese HNPCC and CRC patients with family history, and the identification of those aberrations should be included in the regular genetic analysis for CRC/HNPCC patients.
Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family

Huang Feifei,Tao Xiang,Jiang Wei,Chen Jun,Feng Weiwei

DOI: https://doi.org/10.18282/amor.v3.i3.213

2017-01-01

Advances in Modern Oncology Research

Abstract:Lynch syndrome (LS), an autosomal-dominant disorder with an increased risk of predominantly colorectal and endometrial cancers, is caused by germ-line mutations in mismatch repair genes. The identification of germ-line mutations that predispose to cancer is important to further our understanding of tumorigenesis, guide patient management and inform the best practice for healthcare. A 45-year-old woman with atypical endometrial hyperplasia who suffered colon cancer at the age of 30 years underwent hysterectomy and genetic counseling. Pedigree analysis revealed her family fulfilling the Amsterdam I criteria. Next-generation sequencing was offered to the patient. A mutation in the MLH1 gene, c.1145dupA, was identified and verified by Sanger sequencing. In addition, her nine family members were tested for the mutation. Two were affected (colon cancer at the age of 43 years and 45 years) and one healthy relative carried the same mutation in the MLH1 gene. The mutation resulted in a frame-shift (p.Met383Aspfs*12) located in exon12, as well as a polypeptide truncation of 393 amino acids by the formation of a premature stop codon. An immunohistochemistry analysis of endometrial hyperplasia tissues revealed defects in MLH1 and PMS2 protein expression in the patient. Based on the 2015 American College of Medical Genetics and Genomics (ACMG) guideline, we report this MLH1 c.1145dupA variation to be a pathogenic mutation that contributes to a strongly increased cancer risk in this LS family. Proper screening suggestions were offered to the three affected patients and the healthy carrier. To the best of our knowledge, this germ-line mutation of MLH1 was previously submitted to the Leiden Open Variation Database (LOVD) database, but no comprehensive evidence or supporting observations were reported previously in the literature. The present report found a single nucleotide insertion in exon12 of the MLH1 gene, which can be considered causative of Lynch phenotype. Moreover, identification of individuals at risk for hereditary syndromes is important, as they can benefit from genetic counseling and increased surveillance.
Genetic spectrum of familial colorectal cancer based on Chinese clinical criteria of Lynch syndrome: study based on a multicenter population

Yang Mengyuan,Zhu Lizhen,Zhang Ding,Wu Bin,Gu Yanhong,Wu Tao,Zhang Jingdong,Qiu Meng,Pan Jie,Yuan Ying

DOI: https://doi.org/10.12354/j.issn.1000-8179.2022.20211721

2022-01-01

Chinese Journal of Clinical Oncology

Abstract:ObjectiveLynch syndrome is a malignant tumor syndrome with autosomal dominant inheritance. Preliminary screening of patients based on family history of tumor is currently the main method for Lynch syndrome screening. This study aimed to determine the proportion of colorectal cancer patients who met the clinical criteria of Lynch syndrome in China and were finally diagnosed with Lynch syndrome, as well as the opportunities and challenges that next-generation sequencing brought to the clinical diagnosis and treatment of Lynch syndrome. MethodsFrom February 2017 to October 2019, 85 unrelated patients were enrolled in 7 hospitals (The Second Affiliated Hospital, Zhejiang University School of Medicine; Peking Union Medical College Hospital; Jiangsu Province Hospital; Peking University First Hospital; Liaoning Cancer Hospital & Institute; West China Hospital; Wenzhou Central Hospital) with colorectal cancer who met the Chinese clinical criteria for Lynch syndrome, and detected the germline variants using a next-generation sequencing panel containing 61 genes that have been reported to be related to hereditary tumors. For the variants of uncertain clinical significance, the pathogenic significance of the variants is determined by Sanger sequencing and multiplex fluorescent PCR capillary electrophoresis to detect microsatellite status of tumor tissues. ResultsAmong the colorectal cancer patients who met the clinical criteria for Lynch syndrome in China, 28.2% were detected with pathogenic or likely pathogenic germline variants in Lynch syndrome-related genes, and 15.3% of patients carried variants of uncertain clinical significance of these genes. In the analysis of variants of uncertain significance, we suppose that the MLH1 read-through variant (c.2240_2255 delCTGATCTATACAAAGT) is a pathogenic variant of Lynch syndrome. Additionally, there is still insufficient evidence to show that MLH3 gene exon 2-11 duplication is closely related to the occurrence of hereditary colorectal cancer. ConclusionsThis study found that, also based on colorectal cancer patients who met the Chinese clinical criteria of Lynch syndrome, next-generation sequencing did not improve the diagnosis rate of Lynch syndrome compared with previous researches using Sanger sequencing. At the same time, it also brought a large number of variants of uncertain significance. Therefore, we need to be cautious about the results of genetic test. If necessary, in-depth pedigree research and comprehensive molecular testing should be carried out to clarify the clinical significance of these variants.
A new subtype of Lynch syndrome associated with MSH2 c.354T>A (p. Y118*) identified in a Chinese family: case report and literature review

Lan Zhong,Wenxiang Wang,Yuanqiong Duan,Liang Song,Zhanghuan Li,Kaixuan Yang,Qintong Li,Rutie Yin

DOI: https://doi.org/10.3389/fgene.2024.1440179

IF: 3.7

2024-10-08

Frontiers in Genetics

Abstract:Background: Lynch syndrome (LS) is an autosomal dominant inherited disorder caused by mutations in mismatch repair genes. Genetic counseling is crucial for the prevention and treatment of LS, as individuals with these mutations have an increased lifetime risk of developing multiple cancers. MutS Homolog 2 ( MSH2 ) is a protein-coding gene that plays a key role in LS. A significant number of LS cases are linked to harmful heterozygous mutations in the MSH2 gene. Case Presentation: The proband was a 50-year-old endometrial dedifferentiated carcinoma patient with a dMMR/MSI-H tumor negative for MSH2 / MSH6 expression by immunohistochemistry. Genetic counseling and tumor gene testing were conducted using next-generation sequencing (NGS) technology, which revealed a previously unknown germline MSH2 gene nonsense mutation NM_000251.2:exon2.354T>A (p.Y118*), leading to a diagnosis of LS. Further analysis of this variant in five family members of the patient confirmed its presence in all individuals, with one family member being diagnosed with colorectal cancer (CRC) at the age of 43. The proband received postoperative chemoradiotherapy and achieved a disease-free survival of 2 years, with ongoing follow-up. Conclusion: This study provides evidence that the MSH2 nonsense mutation c.354T>A is a highly likely pathogenic mutation and is responsible for typical LS-associated endometrial carcinoma. It emphasizes the importance of genetic counseling for proband family members to facilitate early diagnosis of LS-related carcinoma.

genetics & heredity
Case Report: A New Subtype of Lynch Syndrome Associated With MSH2 c.1024_1026 Identified in a Chinese Family

Lu Li,Zhe Zhao,Lin Dong,Jia Jia,Ke Su,Hua Bai,Jie Wang

DOI: https://doi.org/10.3389/fmed.2022.811368

IF: 3.9

2022-01-28

Frontiers in Medicine

Abstract:Background Lynch syndrome is an autosomal dominant disorder associated with a high incidence of various cancer types. Multiple variants of mismatch repair genes have been reported for Lynch syndrome. However, the diagnosis in patients with atypical cancer types remains challenging. Specifically, little is known about the genetic background of Lynch syndrome-related renal carcinoma. We present a case wherein a renal carcinoma patient with multiple primary skin tumors harbored a variant that has not been previously shown to be associated with Lynch syndrome. Case Presentation The proband was a 60-year-old Chinese man with a history of Lynch syndrome-related renal carcinoma and recurrent primary skin tumors. Immunohistochemistry revealed loss of MSH2 and MSH6. Sequencing of mismatch repair genes revealed a previously unknown germline MSH2 mutation (c.1024_1026), which results in an amino acid deletion (p.V342). This variant was co-segregated among the carcinoma-affected family members. After six cycles of immunotherapy, a marked regression of the skin tumors was observed. Conclusions We clarify the pathogenic significance of this newly described mutation and suggest immunotherapy for patients with this subtype of Lynch syndrome.

medicine, general & internal
Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Yan Liu,Pengyuan Liu,Weidong Wen,Michael A. James,Yian Wang,Joan E. Bailey-Wilson,Christopher I. Amos,Susan M. Pinney,Ping Yang,Mariza de Andrade,Gloria M. Petersen,Jonathan S. Wiest,Pamela R. Fain,Ann G. Schwartz,Adi Gazdar,Colette Gaba,Henry Rothschild,Diptasri Mandal,Elena Kupert,Juwon Lee,Daniela Seminara,John Minna,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/0008-5472.22382063

2023-01-01

Abstract:Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families

Juyi Li,Haichun Ni,Xiufang Wang,Wenzhuo Cheng,Li Li,Yong Cheng,Chao Liu,Yuanyuan Li,Aiping Deng

DOI: https://doi.org/10.1186/s12957-024-03309-5

2024-01-28

World Journal of Surgical Oncology

Abstract:Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome. This condition is characterized by germline variants in DNA mismatch repair (MMR) genes, including MLH1 , MSH2 , MSH6 , and PMS2 . In this study, we analyzed the molecular defects and clinical manifestations of two families affected with CRC and proposed appropriate individual preventive strategies for all carriers of the variant.

oncology,surgery
Additional File 1 of LIG4 Syndrome: Clinical and Molecular Characterization in a Chinese Cohort

Bijun Sun,Qiuyu Chen,Ying Wang,Danru Liu,Jia‐Woei Hou,Wenjie Wang,Wenjing Ying,Xiaoying Hui,Qinhua Zhou,Jinqiao Sun,Xiaochuan Wang

DOI: https://doi.org/10.6084/m9.figshare.12399368

2020-01-01

Abstract:Additional file 1: Table S1. Immune index of patients with LIG4 mutations.
A Case of a New Lynch Syndrome Variant with a Deletion, C.1024_1026, in the MSH2 Gene in a Chinese Family

Zhe Zhao,Lu Li,Lin Dong,Jia,Ke Su,Hua Bai,Jie Wang

DOI: https://doi.org/10.21203/rs.3.rs-50589/v1

2020-01-01

Abstract:Background Multiple genetic variations have been identified in mismatch repair genes for Lynch Syndrome. However, diagnosis of Lynch Syndrome and its subtypes in patients with atypical cancer types still remains challenging. Little is known about Lynch syndrome-related renal carcinoma and related genes. We present a case of renal carcinoma with multiple primary skin tumors, with a new Lynch Syndrome variant with a deletion in a Chinese family. Case presentation: The patient was a 60-year-old Chinese male with a history of Lynch Syndrome-related renal carcinoma with repeatedly multiple primary skin tumors. Immunohistochemistry revealed loss of MSH2 and MSH6 proteins. Sequencing of mismatch repair genes revealed a previously unknown germline MSH2 mutation (c.1024_1026 del) resulting in an amino acid deletion (p. V342del). This variant was co-segregated among the carcinoma-affected family members. After 6 cycles of immunotherapy, a marked regression of the skin tumor was obtained. Conclusions We clarify the pathogenic significance of this new mutation and suggest immunotherapy for patients with this subtype of Lynch Syndrome.
Case Report of A Li-Fraumeni Syndrome-Like Phenotype with A De Novo Mutation in Chek2

Xuehan Zhuang,Yongping Li,Hongzhi Cao,Ting Wang,Jianghao Chen,Jiayun Liu,Liya Lin,Rui Ye,Xinyang Li,Shuang Liu,Weiyang Li,Yonggang Lv,Juliang Zhang,Chenyang He,Xun Xu,Zhen Wang,Chen Huang,Xiao Liu,Ling Wang

DOI: https://doi.org/10.1097/md.0000000000004251

IF: 1.6

2016-01-01

Medicine

Abstract:Background: Cases of multiple tumors are rarely reported in China. In our study, a 57-year-old female patient had concurrent squamous cell carcinoma, mucoepidermoid carcinoma, brain cancer, bone cancer, and thyroid cancer, which has rarely been reported to date.Methods: To determine the relationship among these multiple cancers, available DNA samples from the thyroid, lung, and skin tumors and from normal thyroid tissue were sequenced using whole exome sequencing.Results: The notable discrepancies of somatic mutations among the 3 tumor tissues indicated that they arose independently, rather than metastasizing from 1 tumor. A novel deleterious germline mutation (chr22: 29091846, G->A, p.H371Y) was identified in CHEK2, a Li-Fraumeni syndrome causal gene. Examining the status of this novelmutation in the patient's healthy siblings revealed its de novo origin.Conclusion: Our study reports the first case of Li-Fraumeni syndrome-like in Chinese patients and demonstrates the important contribution of de novo mutations in this type of rare disease.
Additional File 2 of Genetic Alteration of Chinese Patients with Rectal Mucosal Melanoma

Huan Li,Lujing Yang,Yisheng Lai,Xintong Wang,Xinyin Han,Siyao Liu,Dongliang Wang,Xiaojuan Li,Nana Hu,Yan Kong,Lu Si,Zhongwu Li

DOI: https://doi.org/10.6084/m9.figshare.14692003

2021-01-01

Abstract:Additional file 2: Table S2. CNVs and SVs variants in 36 RMM.
Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Y. Yuan,L. Zhu,D. Xu,C. Liu,X. Mao

DOI: https://doi.org/10.1093/annonc/mdy281.146

IF: 51.769

2018-01-01

Annals of Oncology

Abstract:Background: Mismatch repair deficiency (dMMR) due to germline mutations in DNA repair genes including MLH1, MSH2, MSH6 and PMS2, or somatic aberrant silencing of MLH1, is a well-established feature for Lynch syndrome, a major type of hereditary colorectal cancer (CRC). The purpose of this study is to derive prevalence of germline MMR gene mutations in Chinese population with dMMR CRC. Methods: ColonCore panel is designed for simultaneous detection of microsatellite instabiligy (MSI) status of 22 regions and mutations in 38 CRC-related genes. Whole exons of the 38 genes were covered by the panel. The MSI phenotype detection method was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. Results: Among 1394 postsurgical CRC patients whose MMR status were detected by immunohistochemistry (IHC), 99 patients were dMMR, accounting for 7.1%. The concordance rate was 92.3% between MSI and IHC. Next, we investigated the germline mutation spectrum of dMMR patients. About 26.3% patients harbored pathogenic germline MMR gene mutations, with 13%, 6%, 5% and 2% of patients carrying pathogenic MLH1, MSH2, MSH6 and PMS2 mutations, respectively. Specially, about 30% pathogenic MLH1 mutation occured in splice region. Among patients with pathogenic MMR gene mutations, their first cancer was diagnosed ranging from 22 to 69 years old with median age at diagnosis was 50, and only 57% have a family history of ≥ 1 relative with Lynch syndrome related cancers. Furthermore, 3% harbored pathogenic mutations in other genes. Approximately, 17% of patients harbored MMR gene variants of unknown significance (VUS) and 26% harbored other VUS. The remaining 28% of patients had no pathogenic or VUS mutations from this panel. Conclusions: The prevalence rate of germline pathogenic mutations is 26% in dMMR CRC patients, accounting for 1.8% of all resectable CRC patients. Median age at diagnosis of Lynch syndrome related cancers is 50 years old and nearly 40% Lynch syndrome patients have no family history. Legal entity responsible for the study: Ying Yuan. Funding: Burning Rock Biotech. Disclosure: C. Liu: Burning Rock Biotech. All other authors have declared no conflicts of interest.
The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Ying Yuan,Lizhen Zhu,Dong Xu,Ju Haixing,Yan Sun,Pei-Rong Ding

DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e13518

IF: 45.3

2018-01-01

Journal of Clinical Oncology

Abstract:e13518 Background: Mismatch repair deficiency (dMMR) assessed by microsatellite instability (MSI) or immunohistochemistry (IHC) is a feature of Lynch syndrome, a major hereditary colorectal cancer (CRC). Chinese Lynch syndrome criteria was proposed based on the decreasing family numbers: In a pedigree, it should have at least 2 CRCs, and at least 2 of them are first-degree relatives of each other. Besides, any one of following criteria should be met: 1) at least 1 CRC should have multiple primary synchronous/metachronous colorectal carcinoma/adenoma; 2) at least 1 CRC should be diagnosed before 50 years old; 3) in the pedigree, at least 1 should be diagnosed with other Lynch syndrome-related cancer (i.e. gastric, endometrial, small bowel, ureter, or renal-pelvic, ovarian and hepatobiliary cancers). The purpose of this multi-center study is to derive prevalence of germline mutations in Chinese dMMR CRC, especially taking different screen criteria for Lynch syndrome into consideration. Methods: ColonCore panel is designed for simultaneous detection of MSI and mutations in 41 CRC-related genes by next generation sequencing (NGS). Primary CRC patients with loss of expression of any one of four MMR proteins (MLH1, MSH2, MSH6 and PMS2) in IHC were recruited. DNA was extracted from paired tumor-normal tissue for MSI detection and germline and somatic sequencing by ColonCore panel. Results: A total of 205 patients were enrolled. The MSI detection by NGS achieved 94% concordance with IHC. We revealed 32% patients had pathogenic germline mutations, with 14%, 7%, 5%, 2% and 3% patients carrying MLH1, MSH2, MSH6, PMS2 and other gene mutations respectively. Among all 205 patients, 7%, 12% and 42% patients met Amsterdam II criteria, Chinese Lynch syndrome criteria and revised Bethesda Guidelines respectively. Besides, 100%, 80% and 53% patients had pathogenic mutations and 27%, 24% and 15% patients with pathogenic germline mutations were missed according to Amsterdam II criteria, Chinese Lynch syndrome criteria and revised Bethesda Guidelines respectively. Conclusions: We found that 32% IHC dMMR CRCs have pathogenic germline mutations, and Chinese Lynch syndrome criteria is an effective screening criteria.
Gene mutation analysis of a family with familial generalized lentiginosis

李博,温广东,于聪,张建中,周城

DOI: https://doi.org/10.35541/cjd.20210128

2022-01-01

Chinese Journal of Dermatology

Abstract:Objective:To analyze clinical and genetic characteristics of a family with familial generalized lentiginosis, and to identify the causative gene mutation.Methods:Clinical characteristics and inherited pattern were analyzed in a family with familial generalized lentiginosis. Peripheral blood samples were obtained from the proband, his affected father and healthy mother, and genomic DNA was extracted. PCR was performed to amplify all exons and their flanking sequences of the SASH1 gene, followed by DNA sequencing. The proband′s mother and 100 unrelated healthy controls served as controls to determine the mutation site. Previous literature and gene mutation databases were searched to rule out the possibility that the SASH1 gene mutations were single nucleotide polymorphisms, and to determine whether it was a known mutation.Results:A 4-generation family consisting of 17 members was investigated, and there were 9 patients in the family, including 7 males and 2 females. Patients existed in each generation, and the disease was inherited in an autosomal dominant manner in this family. Gene sequencing revealed a heterozygous duplication mutation c.49_54dupCCCGAG in exon 1 of the SASH1 gene in the proband and his father. This mutation was not found in his mother or healthy controls, and had not been reported in previous literature or gene mutation databases.Conclusion:The heterozygous duplication mutation c.49_54dupCCCGAG in the SASH1 gene is a pathogenic mutation for the clinical manifestations of familial generalized lentiginosis in this family.
Two Novel Germline Mutations of MLH1 and Investigation of Their Pathobiology in Hereditary Non-Polyposis Colorectal Cancer Families in China.

Chao-Fu Wang,Xiao-Yan Zhou,Tai-Ming Zhang,Ye Xu,San-Jun Cai,Da-Ren Shi

DOI: https://doi.org/10.3748/wjg.13.6254

IF: 5.374

2007-01-01

World Journal of Gastroenterology

Abstract:AIM: To detect germline mutations of MLH1, and investigate microsatellite instability and expression of MLH1 in tumor tissues of hereditary non-polyposis colorectal cancer (HNPCC) with two novel germline mutations, and further investigate the pathobiology of the two novel mutations of MLH1.METHODS: RNA was extracted from the peripheral blood of 12 patients from 12 different families that fulfilled the Amsterdam II Criteria for HNPCC. Germline mutations of MLH1 were determined by RT-PCR, followed by cDNA sequencing analysis. PCR-GeneScan analysis was used to investigate microsatellite instability with a panel of five microsatellite markers (BAT26, BAT25, D5S346, D2S123 and mfd15), along with immunohistochemical staining to detect the expression of MLH1 protein in two patients' tumor tissues with novel mutations.RESULTS: Three germline mutations were found in four patients, one of the mutations has previously been reported, but the other two, CGC -> TGC at codon 217 of exon 8 and CCG -> CTG at codon 581 of exon 16, have not been reported. The two patients' tumor tissues with novel mutations had high-frequency microsatellite instability that showed more than two Unstable loci, and both tumors lost their MLH1 protein expression.CONCLUSION: The two novel germline mutations of MLH1 in HNPCC families i.e. CGC -> TGC at codon 217 of exon 8 and CCG -> CTG at codon 581 of exon 16, are very likely to have pathological significance. (c) 2007 WJG. All rights reserved.

Additional File 2: of A Chinese Family Affected by Lynch Syndrome Caused by MLH1 Mutation

A Chinese family affected by lynch syndrome caused by MLH1 mutation

Novel Germline Mutations in MLH1 and PMS2 in Familial Lynch Syndrome

A novel heterozygous large deletion of MSH6 gene in a Chinese family with Lynch syndrome

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

A Novel MLH1 Initiation Codon Mutation (c.3g>t) in a Large Chinese Lynch Syndrome Family with Different Onset Age and Mrna Expression Level

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family

Genetic spectrum of familial colorectal cancer based on Chinese clinical criteria of Lynch syndrome: study based on a multicenter population

A new subtype of Lynch syndrome associated with MSH2 c.354T>A (p. Y118*) identified in a Chinese family: case report and literature review

Case Report: A New Subtype of Lynch Syndrome Associated With MSH2 c.1024_1026 Identified in a Chinese Family

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families

Additional File 1 of LIG4 Syndrome: Clinical and Molecular Characterization in a Chinese Cohort

A Case of a New Lynch Syndrome Variant with a Deletion, C.1024_1026, in the MSH2 Gene in a Chinese Family

Case Report of A Li-Fraumeni Syndrome-Like Phenotype with A De Novo Mutation in Chek2

Additional File 2 of Genetic Alteration of Chinese Patients with Rectal Mucosal Melanoma

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Gene mutation analysis of a family with familial generalized lentiginosis

Two Novel Germline Mutations of MLH1 and Investigation of Their Pathobiology in Hereditary Non-Polyposis Colorectal Cancer Families in China.